Utama › Histiositosis Sel Langerhans › Texas
Kajian klinikal Histiositosis Sel Langerhans di Texas
4 kajian untuk Histiositosis Sel Langerhans sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Dell Children's Medical Center of Central Texas, Austin
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- El Paso Children's Hospital, El Paso
- dan 6 lagi
Mengambil pesertaFasa 2
180 Days – 22 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05828069Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
- Cook Children's Health Care System, Fort Worth
Mengambil pesertaFasa 2
Umur 1 hingga 30 · Semua jantina · Dikemas kini 7 Apr 2026 · NCT06582745Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Medical Center- UTSW, Dallas
- Texas Children's Hospital, Houston
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 18 Sep 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Dell Children's Medical Center, Austin
- Cook Children's Health Care System, Fort Worth
- Texas Children's Hospital, Houston
- dan 2 lagi
Mengambil pesertaFasa 3
Sehingga umur 21 · Semua jantina · Dikemas kini 11 Sep 2025 · NCT02670707Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.